MA (EU) number 
(Invented) 
name 
Strength 
Pharmaceutical 
Form 
Route of 
Administration 
Immediate 
Packaging 
Content 
(concentration) 
Pack size 
EU/1/18/1281/001 
KANJINTI   
150 mg 
EU/1/18/1281/002 
KANJINTI   
420 mg 
Powder for 
concentrate for 
solution for 
infusion 
Powder for 
concentrate for 
solution for 
infusion 
Intravenous use 
vial (glass) 
150 mg 
1 vial  
Intravenous use 
vial (glass) 
420 mg 
1 vial  
1/1 
 
 
 
 
